These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9820441)

  • 21. Identifying patients at risk for hemodialysis underprescription.
    Leon JB; Sehgal AR
    Am J Nephrol; 2001; 21(3):200-7. PubMed ID: 11423689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dialysis is not dialysis is not dialysis! Acute dialysis is different and needs help!
    Paganini EP
    Am J Kidney Dis; 1998 Nov; 32(5):832-3. PubMed ID: 9820456
    [No Abstract]   [Full Text] [Related]  

  • 23. Effective flow performances and dialysis doses delivered with permanent catheters: a 24-month comparative study of permanent catheters versus arterio-venous vascular accesses.
    Canaud B; Leray-Moragues H; Kerkeni N; Bosc JY; Martin K
    Nephrol Dial Transplant; 2002 Jul; 17(7):1286-92. PubMed ID: 12105254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender-specific differences in dialysis quality (Kt/V): 'big men' are at risk of inadequate haemodialysis treatment.
    Kuhlmann MK; König J; Riegel W; Köhler H
    Nephrol Dial Transplant; 1999 Jan; 14(1):147-53. PubMed ID: 10052495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose of dialysis in acute renal failure.
    Luyckx VA; Bonventre JV
    Semin Dial; 2004; 17(1):30-6. PubMed ID: 14717809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction.
    McIntyre CW; Fluck RJ; Freeman JG; Lambie SH
    Clin Nephrol; 2002 Nov; 58(5):376-83. PubMed ID: 12425489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardized hemodialysis prescriptions promote inadequate treatment in patients with large body mass.
    Ifudu O; Mayers JD; Matthew JJ; Fowler AM; Homel P; Friedman EA
    Ann Intern Med; 1998 Mar; 128(6):451-4. PubMed ID: 9499328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose.
    Lowrie EG; Chertow GM; Lew NL; Lazarus JM; Owen WF
    Kidney Int; 1999 Aug; 56(2):729-37. PubMed ID: 10432415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revisiting the hemodialysis dose.
    Leypoldt JK; Cheung AK
    Semin Dial; 2006; 19(2):96-101. PubMed ID: 16551284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kt/V: patients do not get what the physician prescribes.
    LeFebvre JM; Spanner E; Heidenheim AP; Lindsay RM
    ASAIO Trans; 1991; 37(3):M132-3. PubMed ID: 1751079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal replacement therapy in acute renal failure: which index is best for dialysis dose quantification?
    Ratanarat R; Permpikul C; Ronco C
    Int J Artif Organs; 2007 Mar; 30(3):235-43. PubMed ID: 17417763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kt as control and follow-up of the dose at a hemodialysis unit].
    Maduell F; Vera M; Serra N; Collado S; Carrera M; Fernández A; Arias M; Blasco M; Burgadá E; Cases A; Campistol JM
    Nefrologia; 2008; 28(1):43-7. PubMed ID: 18336130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adequacy in dialysis: intermittent versus continuous therapies.
    Misra M; Nolph KD
    Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dose of hemodialysis and patient mortality.
    Held PJ; Port FK; Wolfe RA; Stannard DC; Carroll CE; Daugirdas JT; Bloembergen WE; Greer JW; Hakim RM
    Kidney Int; 1996 Aug; 50(2):550-6. PubMed ID: 8840285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The monitoring of dialysis dose by ionic dialysance-based Kt reveals less dialysis adequacy than the Kt/V(UREA)-based measurement in critically ill patients with acute renal failure].
    Serra Cabañas N; Barros Freiría X; Garro Martínez J; Blasco Pelícano M; Maduell Canals F; Torras Rabasa A; Poch López de Briñas E
    Nefrologia; 2010; 30(2):232-5. PubMed ID: 20393623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urea reduction ratio may be a simpler approach for measurement of adequacy of intermittent hemodialysis in acute kidney injury.
    Liang KV; Zhang JH; Palevsky PM
    BMC Nephrol; 2019 Mar; 20(1):82. PubMed ID: 30841863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of sodium and ultrafiltration modelling on plasma volume changes and haemodynamic stability in intensive care patients receiving haemodialysis for acute renal failure: a prospective, stratified, randomized, cross-over study.
    Paganini EP; Sandy D; Moreno L; Kozlowski L; Sakai K
    Nephrol Dial Transplant; 1996; 11 Suppl 8():32-7. PubMed ID: 9044338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equal levels of blood pressure control in ESRD patients receiving high-efficiency hemodialysis and conventional hemodialysis.
    Velasquez MT; von Albertini B; Lew SQ; Mishkin GJ; Bosch JP
    Am J Kidney Dis; 1998 Apr; 31(4):618-23. PubMed ID: 9531177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of prescribed and delivered doses of dialysis using anthropometrically and bioelectrically measured patient volumes.
    Załuska WT; Schneditz D; Swatowski A; Jaroszyński AJ; Ksiazek A
    Med Sci Monit; 2003 Sep; 9(9):CR405-10. PubMed ID: 12960931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis prescription and delivery in a metropolitan community. The St. Louis Nephrology Study Group.
    Delmez JA; Windus DW
    Kidney Int; 1992 Apr; 41(4):1023-8. PubMed ID: 1513083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.